Adolor Entereg Reduces Hospital Stays By 18 Hours, FDA-Requested Study Finds
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
GlaxoSmithKline/Adolor's postoperative ileus agent Entereg provides a statistically significant reduction in length of hospital stay, according to trial results reported by Adolor Feb. 7